Vancouver, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The Global Prenatal Testing and Newborn Screening Market is projected to be worth USD 10.85 Billion by 2027, according to the latest analysis by Emergen Research. The prenatal testing and newborn screening market is observing substantial growth attributed to the increasing demand for screening genetic disorders in newborn babies. Newborn screening is beneficial in preventing severe disabilities and is considered very promising in saving the lives of infants through initial diagnosis and treatment. Currently, in the U.S., more than 98.0% of the newborn babies born yearly are tested for over 30 curable genetic, endocrine, metabolic, and infectious diseases in the first week after their birth.

Next-generation sequencing technology has paved the way for the identification of chromosomal aberrations with growing efficiency and lowering expenses. The high-risk testing industry is crowded, and continued rivalry is likely to result in substantial declines in the retail sales price of such tests. The prevalence of such studies can be improved with reduced costs in the market for reproductive genetics. The creation of new technology for prenatal testing is gradually increasing due to the rising awareness of the advantages of non-invasive prenatal testing methods.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@

Key Highlights From The Report

  • In March 2020, Agilent Technologies launched three novel microarrays to cater to the growing demand from cytogenetic laboratories performing both prenatal and newborn research.
  • Electrophoresis is gaining substantial traction in the market. Hemoglobin electrophoresis measures hemoglobin in RBCs to detect diseases, including sickle cell disease.
  • Incubator shaker finds widespread usage due to exceptional potential in applications comprising solubility studies and cell aeration & culturing.
  • The market in the Asia Pacific region is projected to grow at the fastest rate in the forecast period due to considerable developments in countries like Japan and China for next-generation sequencing technological integration. Furthermore, improving healthcare infrastructure and increased investment in R&D activities in prenatal testing and newborn screening methodologies are driving the market growth.
  • Key participants include Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@

Emergen Research has segmented the Global Prenatal Testing and Newborn Screening Market on the basis of type, test type, technology, instrument, end-user, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027)
    • Prenatal Testing
    • Newborn Screening
  • Test Type Outlook (Revenue, USD Billion; 2017-2027)
    • Non-Invasive
    • Invasive
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • Mass Spectrometry
    • Electrophoresis
    • Enzyme Immunoassays
    • DNA Assays
  • Instrument Outlook (Revenue, USD Billion; 2017-2027)
    • Ultrasonography
    • Reagent and Assay Kits
    • Tandem Quadrupole Detector
    • Incubator Shaker
    • Hearing Screen Instruments
  • End-User Outlook (Revenue, USD Billion; 2017-2027)
    • Hospitals
    • Maternity & Specialty Clinics
    • Diagnostic Centers

To identify the key trends in the industry and read full summary click on the link:

  • Regional Outlook (Revenue, USD Billion; 2017-2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East  & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. Rest of MEA

Take a Look at our Related Reports:

In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027

Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027

Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@